HIGHLIGHTS
- who: Jia Deng and colleagues from the Department of Biofunction Research, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), Tokyo, Japan have published the research: Anti-Inflammatory Therapy for Temporomandibular Joint Osteoarthritis Using mRNA Medicine Encoding Interleukin-1 Receptor Antagonist, in the Journal: Pharmaceutics 2022, 14, x FOR PEER REVIEW of /2022/
- what: The authors demonstrated the therapeutic effects of IL-1Ra mRNA on TMJOA. While the modified mRNA may preferably be used in clinical practice, the experimental results of joint inflammation suppression, even using wild-type mRNA obtained in this study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.